New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF by Nirros Ponnudurai, Claudia M. Denkinger, Wayne Van Gemert, Madhukar Pai

Get full text

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 by Matteo Zignol, Wayne van Gemert, Dennis Falzon, Charalambos Sismanidis, Philippe Glaziou, Katherine Floyd, Mario Raviglione

Get full text

Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors by Alena Skrahina, Henadz Hurevich, Aksana Zalutskaya, Evgeni Sahalchyk, Andrei Astrauko, Sven Hoffner, Valiantsin Rusovich, Andrei Dadu, Pierpaolo de Colombani, Masoud Dara, Wayne van Gemert, Matteo Zignol

Get full text

Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients—Patients’ an... by Austin Ihesie, Ogoamaka Chukwuogo, Rupert Eneogu, Olugbenga Kayode Daniel, Aderonke Agbaje, Bethrand Odume, Debby Nongo, Charles Ohikhuai, Nera Kadiri-Eneh, Omosalewa Oyelaran, Victor Obianeri, Wayne Van Gemert, Enos Okumu Masini, Cleophas D’auvergne, Urhioke Ochuko, Chukwuma Anyaike, Sunday Olakunle Olarewaju

Get full text

Targeted next-generation sequencing of Mycobacterium tuberculosis from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh by Mohammad Khaja Mafij Uddin, Andrea Maurizio Cabibbe, Rumana Nasrin, Arash Ghodousi, Fahim Alam Nobel, S. M. Mazidur Rahman, Shahriar Ahmed, Md. Fahim Ather, S. M. Abdur Razzaque, Md. Abu Raihan, Pronab Kumar Modak, Jean Luc Berland, Wayne Van Gemert, Sardar Munim Ibna Mohsin, Daniela Maria Cirillo, Sayera Banu

Get full text